Author

Johan Normark

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Determinants of seasonal influenza and COVID-19 vaccine uptake in high-risk individuals in northern Sweden

ABSTRACT Seasonal influenza and COVID-19 vaccination in high-risk individuals prevent disease, disability, and death. Nevertheless, many high-income countries continue to experience suboptimal vaccine coverage. We therefore aimed to identify the remaining vaccination barriers in these settings. We recruited patients seeking emergency department care at a hospital in northern Sweden. Using semi-structured interviews and medical records, we collected high-resolution individual-level data, and linked community-level determinants from national registers. Logistic regression was used to calculate odds ratios (OR) and adjusted odds ratios (aOR) for determinants associated with influenza and COVID-19 vaccination. We included 600 patients of whom 450 were eligible for both vaccines. Coverage among eligible individuals was 52.0% for influenza and 54.2% for COVID-19. Co-administration of both vaccines was high (OR 55.33, 95% CI: 30.86–99.22). Individual-level determinants associated with lower vaccine uptake included male biological sex (aOR: 0.57, 95% CI: 0.37–0.88, younger age (aOR: 0.50, 95% CI: 0.41–0.61), smoking (aOR: 0.43, 95% CI: 0.18–1.02), reduced independence (aOR: 0.59, 95% CI: 0.31–1.10), and age-only eligibility (aOR 0.41, 95% CI: 0.19–0.86). In multimorbid individuals, meeting more eligibility criteria showed no significant association with higher uptake (aOR: 1.14, 95% CI: 0.93–1.39). Finally, we noted only limited influence of community-level determinants. In conclusion, vaccine uptake for influenza and COVID-19 was primarily associated with individual-level determinants, whereas community-level showed little impact. Targeted communication, such as risk-stacking to improve risk-awareness, harmonized eligibility criteria, and co-administration, may help overcome remaining vaccination barriers in high-risk individuals.

Lucas Grape, Wilma Persson, Adam Sergejev et al. · 0 citations